C. David Marsden - Publications

Affiliations: 
Neurology King's College (London), London, England, United Kingdom 

82 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Debono AG, Marsden CD, Asselman P, Parkes JD. Bromocriptine and dopamine receptor stimulation. British Journal of Clinical Pharmacology. 3: 977-82. PMID 22216518 DOI: 10.1111/J.1365-2125.1976.TB00346.X  0.314
1998 Pearce RK, Banerji T, Jenner P, Marsden CD. De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset. Movement Disorders : Official Journal of the Movement Disorder Society. 13: 234-41. PMID 9539335 DOI: 10.1002/Mds.870130207  0.307
1998 Rinne UK, Bracco F, Chouza C, Dupont E, Gershanik O, Marti Masso JF, Montastruc JL, Marsden CD. Early treatment of Parkinson's disease with cabergoline delays the onset of motor complications. Results of a double-blind levodopa controlled trial. The PKDS009 Study Group. Drugs. 55: 23-30. PMID 9483167 DOI: 10.2165/00003495-199855001-00004  0.584
1997 Rinne UK, Bracco F, Chouza C, Dupont E, Gershanik O, Marti Masso JF, Montastruc JL, Marsden CD, Dubini A, Orlando N, Grimaldi R. Cabergoline in the treatment of early Parkinson's disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa. The PKDS009 Collaborative Study Group. Neurology. 48: 363-8. PMID 9040722 DOI: 10.1212/Wnl.48.2.363  0.572
1995 Gnanalingham KK, Jenner P, Hunter AJ, Marsden CD. The differential behavioural effects of benzazepine D1 dopamine agonists with varying efficacies, co-administered with quinpirole in primate and rodent models of Parkinson's disease. Psychopharmacology. 117: 287-297. PMID 7770604 DOI: 10.1007/Bf02246103  0.336
1993 Blunt SB, Jenner P, Marsden CD. Suppressive effect of L-dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine Movement Disorders. 8: 129-133. PMID 8097279 DOI: 10.1002/Mds.870080202  0.309
1992 Burn DJ, Mark MH, Playford ED, Maraganore DM, Zimmerman TR, Duvoisin RC, Harding AE, Marsden CD, Brooks DJ. Parkinson's disease in twins studied with 18F-dopa and positron emission tomography. Neurology. 42: 1894-900. PMID 1407569 DOI: 10.1212/Wnl.42.10.1894  0.49
1992 Lange KW, Löschmann PA, Wachtel H, Horowski R, Jähnig P, Jenner P, Marsden CD. Terguride stimulates locomotor activity at 2 months but not 10 months after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets. European Journal of Pharmacology. 212: 247-52. PMID 1350996 DOI: 10.1016/0014-2999(92)90337-4  0.32
1991 Leenders KL, Salmon EP, Tyrrell P, Perani D, Brooks DJ, Sager H, Jones T, Marsden CD, Frackowiak RS. The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. Archives of Neurology. 47: 1290-8. PMID 2123623 DOI: 10.1001/Archneur.1990.00530120034007  0.31
1990 Rose S, Nomoto M, Jenner P, Marsden CD. Transient depletion of nucleus accumbens dopamine content may contribute to initial akinesia induced by MPTP in common marmosets. Biochemical Pharmacology. 38: 3677-81. PMID 2597167 DOI: 10.1016/0006-2952(89)90572-8  0.423
1989 Temlett JA, Chong PN, Oertel WH, Jenner P, Marsden CD. The D-1 dopamine receptor partial agonist, CY 208-243, exhibits antiparkinsonian activity in the MPTP-treated marmoset. European Journal of Pharmacology. 156: 197-206. PMID 2977118 DOI: 10.1016/0014-2999(88)90322-6  0.375
1989 Nomoto M, Stahl S, Jenner P, Marsden CD. Antiparkinsonian activity of (+)-PHNO in the MPTP-treated common marmoset. Movement Disorders : Official Journal of the Movement Disorder Society. 2: 37-45. PMID 2904119 DOI: 10.1002/Mds.870020105  0.303
1989 Temlett JA, Quinn NP, Jenner PG, Marsden CD, Pourcher E, Bonnet AM, Agid Y, Markstein R, Lataste X. Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 4: 261-5. PMID 2571082 DOI: 10.1002/mds.870040307  0.324
1989 Stewart BR, Jenner P, Marsden CD. Induction of purposeless chewing behaviour in rats by 5-HT agonist drugs. European Journal of Pharmacology. 162: 101-7. PMID 2524394 DOI: 10.1016/0014-2999(89)90608-0  0.31
1989 Rose S, Nomoto M, Jackson EA, Gibb WRG, Jenner P, Marsden CD. Treatment with a selective MAO B inhibitor prevents loss of dopamine in the nucleus accumbens of MPTP-treated common marmosets. Neuropharmacology. 28: 1211-1216. PMID 2512516 DOI: 10.1016/0028-3908(89)90213-X  0.32
1989 Ueki A, Chong P, Albanese A, Rose S, Chivers J, Jenner P, Marsden C. Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxin. Neuropharmacology. 28: 1089-1097. PMID 2510050 DOI: 10.1016/0028-3908(89)90122-6  0.307
1989 Rose S, Nomoto M, Kelly E, Kilpatrick G, Jenner P, Marsden CD. Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP. Neuroscience Letters. 101: 305-310. PMID 2505199 DOI: 10.1016/0304-3940(89)90550-8  0.41
1988 Jenner P, Boyce S, Marsden CD. Receptor changes during chronic dopaminergic stimulation. Journal of Neural Transmission-Supplement. 27: 161-175. PMID 2900291 DOI: 10.1007/978-3-7091-8954-2_14  0.301
1988 Moser A, Reavill C, Liebetrau A, Jenner P, Marsden CD, Cramer H. Dopamine and somatostatin modulated adenylate cyclase activity in the rat caudate-putamen following unilateral cortical ablation. Experimental Brain Research. 68: 406-10. PMID 2891560 DOI: 10.1007/Bf00248805  0.318
1987 De Ceballos ML, Boyce S, Jenner P, Marsden CD. Alterations in [Met5]- and [Leu5]enkephalin and neurotensin content in basal ganglia induced by the long-term administration of dopamine agonist and antagonist drugs to rats. European Journal of Pharmacology. 130: 305-9. PMID 3792452 DOI: 10.1016/0014-2999(86)90282-7  0.398
1987 Dewar D, Jenner P, Marsden CD. Effects of opioid agonist drugs on the in vitro release of 3H-GABA, 3H-dopamine and 3H-5HT from slices of rat globus pallidus. Biochemical Pharmacology. 36: 1738-1741. PMID 3297065 DOI: 10.1016/0006-2952(87)90062-1  0.32
1987 Jenner P, Marsden CD. Chronic pharmacological manipulation of dopamine receptors in brain. Neuropharmacology. 26: 931-40. PMID 2889159 DOI: 10.1016/0028-3908(87)90072-4  0.303
1987 Hong M, Jenner P, Marsden CD. Comparison of the acute actions of amine-depleting drugs and dopamine receptor antagonists on dopamine function in the brain in rats. Neuropharmacology. 26: 237-245. PMID 2884588 DOI: 10.1016/0028-3908(87)90214-0  0.314
1987 Kelly E, Jenner P, Marsden CD. Comparison of changes in locomotor activity with striatal homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations following the bilateral intranigral injection of dopamine agonist drugs in rats. The Journal of Pharmacy and Pharmacology. 39: 196-202. PMID 2883284 DOI: 10.1111/J.2042-7158.1987.Tb06248.X  0.431
1986 Simpson MDC, Jenner P, Marsden CD. Hypophysectomy may non-selectively alter pharmacokinetic parameters to enhance the ability of haloperidol to increase striatal dopamine receptor density in the rat Biochemical Pharmacology. 35: 3501-3506. PMID 3768037 DOI: 10.1016/0006-2952(86)90618-0  0.385
1986 Simpson MDC, Jenner P, Marsden CD. Hyperprolactinaemia does not alter specific striatal 3H-spiperone binding in the rat Biochemical Pharmacology. 35: 3203-3208. PMID 3768017 DOI: 10.1016/0006-2952(86)90414-4  0.37
1986 Quinn NP, Marsden CD. Menstrual-related fluctuations in Parkinson's disease Movement Disorders : Official Journal of the Movement Disorder Society. 1: 85-87. PMID 3504235 DOI: 10.1002/Mds.870010112  0.302
1986 Nomoto M, Jenner P, Marsden CD. Alterations in motor behaviour produced by the isomers of 3-PPP in the MPTP-treated marmoset. European Journal of Pharmacology. 121: 123-8. PMID 3082655 DOI: 10.1016/0014-2999(86)90401-2  0.389
1986 Quinn N, Critchley P, Parkes D, Marsden CD. When should levodopa be started? Lancet (London, England). 2: 985-6. PMID 2877169 DOI: 10.1016/S0140-6736(86)90642-2  0.346
1985 Rupniak NM, Kilpatrick G, Hall MD, Jenner P, Marsden CD. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats. Psychopharmacology. 84: 512-9. PMID 6441952 DOI: 10.1007/Bf00431458  0.32
1985 Rupniak NM, Mann S, Hall MD, Fleminger S, Kilpatrick G, Jenner P, Marsden CD. Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat. Psychopharmacology. 84: 503-11. PMID 6441951 DOI: 10.1007/BF00431457  0.327
1985 Rupniak NM, Hall MD, Mann S, Fleminger S, Kilpatrick G, Jenner P, Marsden CD. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat. Biochemical Pharmacology. 34: 2755-63. PMID 4040370 DOI: 10.1016/0006-2952(85)90577-5  0.416
1985 Kelly E, Jenner P, Marsden CD. The effects of dopamine and dopamine agonists on the release of 3H-GABA and 3H-5HT from rat nigral slices. Biochemical Pharmacology. 34: 2655-62. PMID 3925957 DOI: 10.1016/0006-2952(85)90563-5  0.359
1985 Boyce S, Kelly E, Davis A, Fleminger S, Jenner P, Marsden CD. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors. Biochemical Pharmacology. 34: 1665-9. PMID 2988552 DOI: 10.1016/0006-2952(85)90632-X  0.306
1985 Rupniak NM, Hall MD, Kelly E, Fleminger S, Kilpatrick G, Jenner P, Marsden CD. Mesolimbic dopamine function is not altered during continuous chronic treatment of rats with typical or atypical neuroleptic drugs. Journal of Neural Transmission. 62: 249-66. PMID 2863324 DOI: 10.1007/Bf01252240  0.317
1984 Kelly E, Jenner P, Marsden CD. Behavioural effects mediated by unilateral nigral dopamine receptor stimulation in the rat. Experimental Brain Research. 55: 243-52. PMID 6611272 DOI: 10.1007/Bf00237275  0.316
1984 Boyce S, Kelly E, Reavill C, Jenner P, Marsden CD. Repeated administration of N-methyl-4-phenyl 1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neurones. Biochemical Pharmacology. 33: 1747-52. PMID 6610420 DOI: 10.1016/0006-2952(84)90344-7  0.429
1984 Rupniak NMJ, Jenner P, Marsden CD. Enhancement of stereotypy induced by nomifensine in rats during continuous chronic haloperidol treatment Neuroscience Letters. 50: 63-65. PMID 6541767 DOI: 10.1016/0304-3940(84)90463-4  0.391
1984 Hall MD, Cooper DR, Fleminger S, Rupniak NMJ, Jenner P, Marsden CD. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of l-DOPA to rats Neuropharmacology. 23: 545-553. PMID 6539859 DOI: 10.1016/0028-3908(84)90028-5  0.302
1984 Jenner P, Rupniak NM, Rose S, Kelly E, Kilpatrick G, Lees A, Marsden CD. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset. Neuroscience Letters. 50: 85-90. PMID 6436758 DOI: 10.1016/0304-3940(84)90467-1  0.427
1984 Kerwin R, Rupniak NMJ, Jenner P, Marsden CD. Functional increase in striatal dopaminergic activity following continuous long-term treatment with trifluoperazine Neuroscience Letters. 45: 329-334. PMID 6145129 DOI: 10.1016/0304-3940(84)90247-7  0.349
1984 Kilpatrick GJ, Jenner P, Marsden CD. The binding of [3H]N-(chloroethyl)-norapomorphine to rat striatal membranes European Journal of Pharmacology. 107: 71-78. PMID 6084599 DOI: 10.1016/0014-2999(84)90093-1  0.375
1983 Murugaiah K, Fleminger S, Theodorou A, Jenner P, Marsden CD. Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intake Biochemical Pharmacology. 32: 2495-2499. PMID 6684429 DOI: 10.1016/0006-2952(83)90008-4  0.384
1983 Reavill C, Jenner P, Marsden CD. Differentiation of dopamine agonists using drug-induced rotation in rats with unilateral or bilateral 6-hydroxydopamine destruction of ascending dopamine pathways. Biochemical Pharmacology. 32: 865-870. PMID 6301501 DOI: 10.1016/0006-2952(83)90589-0  0.403
1983 Luscombe G, Jenner P, Marsden CD. Alterations in brain 5HT and tryptamine content during indoleamine-induced myoclonus in guinea pigs Biochemical Pharmacology. 32: 1857-1864. PMID 6192824 DOI: 10.1016/0006-2952(83)90050-3  0.302
1983 Hall MD, Jenner P, Marsden CD. Differential labelling of dopamine receptors in rat brain in vivo: comparison of [3H]piribedil, [3H]S 3608 and [3H]N,n-propylnorapomorphine. European Journal of Pharmacology. 87: 85-94. PMID 6188621 DOI: 10.1016/0014-2999(83)90053-5  0.383
1983 Rupniak N, Hong M, Mansfield S, Fleminger S, Dyer R, Jenner P, Marsden CD. Elevation of circulating prolactin concentrations may not cause striatal dopamine receptor supersensitivity. European Journal of Pharmacology. 93: 195-200. PMID 6139285 DOI: 10.1016/0014-2999(83)90137-1  0.306
1983 Reynolds LM, Dyer RG, Jenner P, Marsden CD. Hypophysectomy does not prevent increased cerebral dopamine turnover following sulpiride administration. The Journal of Pharmacy and Pharmacology. 35: 170-4. PMID 6132975 DOI: 10.1111/J.2042-7158.1983.Tb04299.X  0.311
1983 Anker L, Testa B, Van De Waterbeemd H, Bornand-Crausaz A, Theodorou A, Jenner P, Marsden CD. Basicity, Lipophilicity, and Lack of Receptor Interaction ofN-Aminoalkylbenzamides andN-Aminoalkyl-o-anisamides as Model Compounds of Dopamine Antagonists Helvetica Chimica Acta. 66: 542-556. DOI: 10.1002/Hlca.19830660215  0.307
1982 Taylor RJ, Reavill C, Jenner P, Marsden CD. Circling behavior following unilateral kainic acid injections into rat striatum. European Journal of Pharmacology. 76: 211-22. PMID 7333356 DOI: 10.1016/0014-2999(81)90503-3  0.325
1982 Jenner P, Hall MD, Murugaiah K, Rupniak N, Theodorou A, Marsden CD. Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivity Biochemical Pharmacology. 31: 325-328. PMID 7200363 DOI: 10.1016/0006-2952(82)90178-2  0.426
1982 Jenner P, Rupniak NM, Hall MD, Dyer R, Leigh N, Marsden CD. Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatment. European Journal of Pharmacology. 76: 31-6. PMID 6119220 DOI: 10.1016/0014-2999(81)90006-6  0.416
1980 Marsden CD, Duvoisin R. Scoliosis and Parkinson's Disease Jama Neurology. 37: 253-254. PMID 7362496 DOI: 10.1001/Archneur.1980.00500530091025  0.552
1980 Clow A, Theodorou A, Jenner P, Marsden CD. A comparison of striatal and mesolimbic dopamine function in the rat during 6-month trifluoperazine administration Psychopharmacology. 69: 227-233. PMID 6774362 DOI: 10.1007/Bf00433087  0.315
1980 Jenner P, Clow A, Reavill C, Theodorou A, Marsden CD. Stereoselective actions of substituted benzamide drugs on cerebral dopamine mechanisms Journal of Pharmacy and Pharmacology. 32: 39-44. PMID 6102125 DOI: 10.1111/J.2042-7158.1980.Tb12842.X  0.311
1980 Reavill C, Leigh N, Jenner P, Marsden CD. Dopamine-mediated circling behaviour does not involve the nigro-tectal pathway. Experimental Brain Research. 37: 309-16. PMID 315328 DOI: 10.1007/Bf00237716  0.304
1978 Bédard P, Parkes JD, Marsden CD. Effect of new dopamine-blocking agent (oxiperomide) on drug-induced dyskinesias in Parkinson's disease and spontaneous dyskinesias. British Medical Journal. 1: 954-6. PMID 638546 DOI: 10.1136/bmj.1.6118.954  0.327
1978 Pycock CJ, Marsden CD. The rotating rodent: a two component system? European Journal of Pharmacology. 47: 167-75. PMID 340238 DOI: 10.1016/0014-2999(78)90388-6  0.428
1978 Jenner P, Pycock C, Marsden CD. The effect of chronic administration and withdrawal of amphetamine on cerebral dopamine receptor sensitivity. Psychopharmacology. 58: 131-6. PMID 98779 DOI: 10.1007/Bf00426895  0.327
1978 Dolphin A, Jenner P, Marsden CD. 3-Methoxy-4-hydroxyphenylglycol sulphate (MOPEG-SO4) as an index of cerebral noradrenaline turnover following depletion of transmitter stores in the rat. The Journal of Pharmacy and Pharmacology. 30: 580-2. PMID 29100 DOI: 10.1111/J.2042-7158.1978.Tb13329.X  0.424
1977 Parkes JD, Debono AG, Marsden CD. Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa. Journal of Neurology, Neurosurgery, and Psychiatry. 39: 1101-8. PMID 1036999 DOI: 10.1136/jnnp.39.11.1101  0.302
1977 Sawaya MC, Dolphin A, Jenner P, Marsden CD, Meldrum BS. Noradrenaline-sensitive adenylate cyclase in slices of mouse limbic forebrain: characterisation and effect of dopaminergic agonists. Biochemical Pharmacology. 26: 1877-84. PMID 911341 DOI: 10.1016/0006-2952(77)90161-7  0.498
1977 Dolphin A, Christina M, Sawaya MC, Jenner P, Marsden CD. Behavioural and biochemical effects of chronic reduction of cerebral noradrenaline receptor stimulation. Naunyn-Schmiedeberg's Archives of Pharmacology. 299: 167-73. PMID 909612 DOI: 10.1007/Bf00498559  0.542
1977 Pycock CJ, Marsden CD. Central deopaminergic receptor supersensitivity and its relevance to Parkinson's disease. Journal of the Neurological Sciences. 31: 113-21. PMID 833607 DOI: 10.1016/0022-510X(77)90009-0  0.31
1977 Donaldson IM, Dolphin AC, Jenner P, Pycock C, Marsden CD. Rotational behaviour produced in rats by unilateral electrolytic lesions of the ascending noradrenergic bundles. Brain Research. 138: 487-509. PMID 597720 DOI: 10.1016/0006-8993(77)90685-0  0.503
1977 Elliott PN, Jenner P, Huizing G, Marsden CD, Miller R. Substituted benzamides as cerebral dopamine antagonists in rodents. Neuropharmacology. 16: 333-42. PMID 559256 DOI: 10.1016/0028-3908(77)90070-3  0.317
1977 Pycock CJ, Jenner PG, Marsden CD. The interaction of clonidine with dopamine-dependent behaviour in rodents. Naunyn-Schmiedeberg's Archives of Pharmacology. 297: 133-41. PMID 558529 DOI: 10.1007/BF00499922  0.331
1977 Bedard P, Parkes JD, Marsden CD. Nomifensine in Parkinson's disease. British Journal of Clinical Pharmacology. 187S-190S. PMID 334223 DOI: 10.1111/J.1365-2125.1977.TB05751.X  0.307
1977 Dolphin AC, Jenner P, Sawaya MC, Marsden CD, Testa B. The effect of bromocriptine on locomotor activity and cerebral catecholamines in rodents. The Journal of Pharmacy and Pharmacology. 29: 727-34. PMID 22618 DOI: 10.1111/J.2042-7158.1977.Tb11450.X  0.524
1976 Dolphin A, Jenner P, Marsden CD. Modification of the L-DOPA reversal of reserpine akinesia by inhibitors of dopamine-beta-hydroxylase. European Journal of Pharmacology. 35: 135-44. PMID 1253815 DOI: 10.1016/0014-2999(76)90308-3  0.572
1976 Dolphin A, Jenner P, Marsden CD. Noradrenaline synthesis from L-DOPA in rodents and its relationship to motor activity. Pharmacology, Biochemistry, and Behavior. 5: 431-9. PMID 1005491 DOI: 10.1016/0091-3057(76)90107-6  0.49
1976 Donaldson IM, Dolphin A, Jenner P, Marsden CD, Pycock C. The involvement of noradrenaline in motor activity as shown by rotational behaviour after unilateral lesions of the locus coeruleus. Brain : a Journal of Neurology. 99: 427-46. PMID 1000281 DOI: 10.1093/Brain/99.3.427  0.502
1976 Costall B, Marsden CD, Naylor RJ, Pycock CJ. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain. Brain Research. 118: 87-113. PMID 990957 DOI: 10.1016/0006-8993(76)90843-X  0.328
1976 Dolphin AC, Jenner P, Marsden CD. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice. Pharmacology, Biochemistry, and Behavior. 4: 661-70. PMID 981283 DOI: 10.1016/0091-3057(76)90217-3  0.519
1976 Donaldson I, Dolphin A, Jenner P, Marsden CD, Pycock C. The roles of noradrenaline and dopamine in contraversive circling behaviour seen after unilateral electrolytic lesions of the locus coeruleus. European Journal of Pharmacology. 39: 179-91. PMID 976315 DOI: 10.1016/0014-2999(76)90126-6  0.506
1976 Donaldson IM, Dolphin A, Jenner P, Marsden CD, Pycock C. Contraversive circling behaviour produced by unilateral electrolytic lesions of the ventral noradrenergic bundle mimicking the changes seen with unilateral electrolytic lesions of the locus coeruleus. The Journal of Pharmacy and Pharmacology. 28: 329-31. PMID 6733 DOI: 10.1111/J.2042-7158.1976.Tb04171.X  0.413
1975 Duvoisin RC, Marsden CD. Note on the scoliosis of Parkinsonism Journal of Neurology, Neurosurgery and Psychiatry. 38: 787-793. PMID 1185199 DOI: 10.1136/jnnp.38.8.787  0.533
1975 Jenner P, Marsden CD. The influence of piribedil (ET495) on components of locomotor activity. European Journal of Pharmacology. 33: 211-215. PMID 1175688 DOI: 10.1016/0014-2999(75)90160-0  0.366
1975 Dolphin A, Jenner P, Marsden CD, Pycock C, Tarsy D. Pharmacological evidence for cerebral dopamine receptor blockade by metoclopramide in rodents. Psychopharmacologia. 41: 133-8. PMID 1171487 DOI: 10.1007/Bf00421070  0.548
1975 Parkes JD, Tarsy D, Marsden CD, Bovill KT, Phipps JA, Rose P, Asselman P. Amphetamines in the treatment of Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 38: 232-7. PMID 1097600 DOI: 10.1136/jnnp.38.3.232  0.314
1974 Marsden CD, Dolphin A, Duvoisin RC, Jenner P, Tarsy D. Role of noradrenaline in levodopa reversal of reserpine akinesia. Brain Research. 77: 521-5. PMID 4854165 DOI: 10.1016/0006-8993(74)90643-X  0.607
1974 Duvoisin RC, Marsden CD. Reversal of reserpine-induced bradykinesia by a-methyldopa - new light on its modus operandi Brain Research. 71: 178-182. PMID 4821419 DOI: 10.1016/0006-8993(74)90204-2  0.443
Show low-probability matches.